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The effects of verapamil were compared with those of
nitroprusside at matched mean arterial pressures and heart
rates in 10 symptomatic hypertensive patients during car-
diac catheterization . Simultaneous radionuclide angiogra-
phy and micromanometer pressure measurements were
obtained to assess left ventricular pressure-volume rela-
tions. Compared with control conditions, verapamil in-
creased left ventricular end-diastolic volume index from 57
± 16 to 70 ± 8 ml/m (p = 0.05) without a significant
increase in left ventricular end-diastolic pressure (from 10
± 4 to 13 ± 6 mm Hg). Despite a downward and rightward
shift in the end-systolic pressure-volume relation indicating
negative inotropic effects, ejection fraction did not decrease
significantly (from 5 ± 9% to 46 ± 9%); cardiac index and
stroke volume index remained unchanged . The change in
stroke volume index with verapamil was directly related to
the magnitude of change in end-diastolic volume index (r =
0.8 , p < 0.005), suggesting that the increase in end-
diastolic volume did not arise purely from negative inotro-
pic effects . Systemic vascular resistance index decreased
from 4 ± 8 to 34 ± 7 mm Hg-min- m /liter (p < 0 .05) .
Congestive heart failure is a common complication of
chronic systemic hypertension (1), and left ventricular sys-
tolic dysfunction is the usual underlying cause ( ) . However,
left ventricular diastolic dysfunction occurs in patients with
systemic hypertension (3,4), and frank congestive heart
failure can occur in patients with preserved systolic function
(5,6) .
Antihypertensive drugs alter left ventricular function by a
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In contrast, nitroprusside decreased left ventricular
end-diastolic volume index from 57 ± 16 to 41 ± 10 ml/m
(p < 0.05), cardiac index from 3 . ± 0.7 to .8 ± 0 .6
liters/min per m (p < 0.05) and stroke volume index
from 8 ± 6 to 4 ± 5 ml/m
(p
< 0.01), with no change in
systemic vascular resistance index (40 ± 10 mm
Hg-min m ). The end-systolic pressure-volume relation
shifted downward and leftward in all patients, stemming
from altered left ventricular loading .
Thus, in equihypotensive doses, verapamil and nitro-
prusside have markedly different effects on left ventricular
function. The peripheral vasodilation and apparent im-
provement in left ventricular filling during verapamil bal-
anced the negative inotropic effects, resulting in mainte-
nance of stroke volume and cardiac index . The primary
hypotensive effect of verapamil was a decrease in systemic
vascular resistance, whereas that of nitroprusside was a
decrease in cardiac index stemming from reduced left
ventricular preload .
(J Am Coll Cardiol 1989 :14:515- )
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variety of mechanisms, predominantly by affecting left ven-
tricular loading conditions . Calcium channel antagonists
may also affect left ventricular function directly through
negative inotropic actions . The effects of calcium channel
antagonists on diastolic function in hypertensive patients
have not been investigated intensively . Verapamil, nife-
dipine and diltiazem have been shown to improve left
ventricular relaxation and filling in patients with other car-
diac disorders including hypertrophic cardiomyopathy (7-
13) and coronary artery disease (14-16) . The purpose of this
investigation was to study the acute effects of the calcium
channel antagonist verapamil on systolic and diastolic left
ventricular function in patients with systemic hypertension .
To evaluate the pharmacologic effects that were independent
of changes in blood pressure or heart rate, verapamil was
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compared with nitroprusside at equihypotensive doses dur-
ing atrial pacing .
Methods
Patient selection .
We studied 10 patients with systemic
hypertension who had symptoms of angina pectoris or
dyspnea but no evidence of coronary artery disease . There
were seven men and three women, ranging in age from 43 to
6 years (mean 51) . Each patient had a history of hyperten-
sion requiring therapy, persistent hypertension during hos-
pitalization and a mean arterial pressure of >I 10 mm Hg at
cardiac catheterization .
Noninvasive evaluation . Each patient was hospitalized
and underwent routine admission evaluation . Antihyperten-
sive and cardioactive medications were discontinued >_48 h
before study except for one patient who received a single
dose of hydralazine 3 h before study . Patients underwent
M-mode and two-dimensional echocardiography, and mea-
surements of chamber size and wall thickness were made
according to previously described methods (17). Radionu-
clide angiography was performed, and left ventricular ejec-
tion fraction and indexes of left ventricular diastolic filling
were calculated as previously described (18) . No patient had
evidence of coexistent valvular heart disease or dilated or
hypertrophic cardiomyopathy
. For the group, the mean
ventricular septal dimension was 14 -* 3 mm, left ventricular
free wall dimension was 1
± 4 mm and left ventricular
end-systolic cavity dimension was 34 ± 5 mm . The rest
ejection fraction by radionuclide angiography was 54 ± 10%
as compared with our lower normal limit of 45% (18) . All
patients had evidence of impaired left ventricular diastolic
filling at rest, with reduced peak filling rate (<
.5 end-
diastolic vol/s), prolonged time to peak filling rate (> 180 ms)
or both .
Cardiac catheterization protocol.
The study protocol was
approved by the Institutional Review Board of the National
Heart, Lung, and Blood Institute, and all patients gave
informed consent before cardiac catheterization . Patients
were premedicated 1 h before study with diazepam (10 mg
orally)
. During cardiac catheterization, arterial pressure was
monitored with use of an indwelling 0 gauge catheter in the
brachial artery . Pulmonary artery pressure and cardiac out-
put were measured with a balloon-tipped thermodilution
catheter, and cardiac output was recorded as the mean of at
least three measurements that were within 10% agreement .
A thermodilution coronary sinus catheter (Elecath Cor-
poration) was positioned with the catheter tip at the junction
of the great cardiac vein and anterior interventricular vein by
using manual injection of contrast medium to confirm cath-
eter position . The catheter was maintained in stable position
by repeatedly assessing the relation of the catheter to bone
landmarks by using fluoroscopy . Coronary blood flow was
measured by the thermodilution technique according to
previously described methods (19) .
At the beginning of the procedure, red blood cells were
labeled in vivo with 0 to 5 mCi of technetium-99m . Ten
minutes after administration of technetium-99m, heparin
sulfate (5,000 U, intravenously) was administered for anti-
coagulation . Coronary arteriography was performed with
use of multiple angulated views to confirm the absence of
significant coronary artery disease (defined as >50% narrow-
ing of the lumen of a major coronary artery)
. A microma-
nometer-tipped catheter (Millar Instruments) was then posi-
tioned in the left ventricle for pressure monitoring, and a
portable gamma camera was positioned over the left thorax
for acquisition of scintigraphic data .
Study sequence and pharmacologic interventions . Base-
line hemodynamic and scintigraphic studies were initiated
15 min after any administration of contrast medium ( 0) .
Baseline data obtained included heart rate, systemic blood
pressure, left ventricular pressure, cardiac output, great
cardiac vein flow and scintigraphic data
. In anticipation of
nitroprusside and verapamil causing reflex tachycardia, the
patient was then atrially paced using the coronary sinus
catheter at heart rates of 100 and 130 beats/min for 3 min at
each pacing rate to enable subsequent comparison of drug
effects at similar heart rates . At each pacing rate, the
hemodynamic and scintigraphic data were again obtained .
Patients who developed atrioventricular (AV) block during
pacing were given atropine (0 .5 mg intravenously) .
Nitroprusside and verapamil were sequentially adminis-
tered and titrated to achieve a
0% reduction in mean
arterial pressure
to enable measurement of drug effects at
comparable systemic arterial pressure . Nitroprusside was
administered intravenously at an initial infusion rate of 0 .5
µg/kg per min, and the infusion rate was increased by 0 .5
µg/kg per min every min until an approximate
0%
reduction in mean arterial pressure was achieved
. The
hemodynamic and scintigraphic data were recorded at the
spontaneous heart rate and during atrial pacing at 100 and
130 beats/min . The nitroprusside infusion was discontinued
and, when heart rate and systemic pressure returned to
baseline, verapamil was administered as an intravenous
bolus of 0
.1 mg/kg followed by an intravenous infusion of
0.005 mg/kg per min
. The infusion was increased by 0
.005
mg/kg per min every min until an approximate 0%
reduction in mean arterial pressure was achieved, and he-
modynamic and scintigraphic data were recorded at the
spontaneous heart rate and during atrial pacing at 100 and
130 beats/min .
Pressure-volume analysis
. Scintigraphic data were col-
lected with use of a mobile gamma camera equipped with a
high sensitivity parallel hole collimator positioned over the
left thorax in a modified left anterior oblique position for
optimal separation of the left from the right ventricle
.
Electrocardiogram (ECG)-gated equilibrium scintillation
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data were collected in LIST mode to a preset count limit of
10 million counts for each baseline study and to a preset time
comprising the middle min of each 3 min study period
during pacing . High temporal resolution ( 0 ms/frame)
left ventricular time-activity curves representing relative
changes in left ventricular volume during the average cardiac
cycle were generated from the cardiac image sequence after
background correction and exclusion of extrasystolic and
postextrasystolic cycles . End-diastolic counts, end-systolic
counts, stroke counts and ejection fraction were computed
for each study after correction for physical decay of the
isotope. Simultaneous determination of thermodilution car-
diac output permitted calculation of absolute left ventricular
volumes .
Left ventricular pressure data obtained simultaneously
with the scintigraphic data were also collected in LIST mode
with use of ECG gating and cycles identical to those used in
constructing the time-activity curves . The pressure data
were obtained at an acquisition rate of 00/s (4 ms/point) and
were then condensed to 0 ms/point to correspond to the
scintigraphic volume data . The resulting left ventricular
pressure-time curve and time-activity curve were then com-
bined automatically to create loops representing high tem-
poral resolution ( 0 ms) pressure-volume relations through-
out the average cardiac cycle .
Data analysis . The hemodynamic effects of nitroprusside
and verapamil were compared with each other and with
control conditions by choosing the rest or pacing sequences
that allowed comparisons at the lowest, most closely
matched heart rates in each patient . It was not feasible to
choose arbitrarily a uniform paced heart rate for all patients
with which to compare the effects of the drugs because
BRUSH ET AL
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Table 1. Hemodynamic Effects of Nitroprusside and Verapamil at Spontaneous Heart Rates in 10 Patients
C = control ; LV = left ventricular : N = nitroprusside ; SVRI = systemic vascular resistance index : V = verapamil .
nitroprusside caused reflex tachycardia in some patients and
verapamil caused AV block at higher paced heart rates in
others. In each patient, however, it was possible to select a
condition either at the spontaneous heart rate or during
pacing that allowed close matching of heart rate during
control conditions and during infusion of each drug .
Mean arterial pressure was calculated electronically from
the arterial pressure recording . Cardiac index was calculated
as cardiac output divided by body surface area . Systemic
vascular resistance index was calculated as mean arterial
pressure divided by cardiac index . Stroke volume index was
calculated as cardiac index divided by heart rate ; end-
diastolic volume index was calculated as stroke volume
index divided by ejection fraction ; and end-systolic volume
index was calculated as end-diastolic volume index minus
stroke volume index . Coronary resistance was calculated as
mean arterial pressure divided by coronary blood flow .
To assess left ventricular pressure decline during isovolu-
mic relaxation, the high temporal resolution (4 ms/point) left
ventricular pressure-time data were analyzed . The time
constant (T) was computed from the equation P = Po e +
C, where Po = pressure at the time of maximal negative
dP/dt, t = time, C = the baseline asymptote to which the
exponential would decay ( 1). We also computed the half-
time (T-1/ ) of pressure decay during isovolumic relaxation .
T-1/ was computed according to the method of Mirsky ( )
as the time required for the left ventricular pressure to
decline to one-half of the pressure at peak negative first
derivative of left ventricular pressure (dP/dt) .
Statistical methods . Data are represented as mean values
± SD. The effects of verapamil and nitroprusside relative to
each other and to baseline conditions were analyzed with
Patient
No .
Heart Rate
(beats/min)
Mean Arterial
Pressure (mm Hg)
Cardiac Index
(liters/min
per m )
SVRI
(mm
Hg-min-m/liter)
Stroke Volume
Index
( MI/M )
LV
End-Diastolic
Pressure
(mm Hg)
LV Ejection
Fraction (%)
C N V
C N V C N V C N V C N V
C
N V C
N V
1 80 1 5 105 108 90 100 3 .8 3 .3 3 .9 8
7 6 48 6 37 9 9 lI 47 55 44
88 108 101
1 8 1 0 1 0 .4 .4 .4 53 50 50 7 4 6 4 17
57 70 54
3 110 130 13 1 0 98 100 .6 3
.1 46 - 3 4 - 3 8 6 5 37 39 37
4 7 1 4 90 1 104 104 .7 .7 3 .3 45 39 3 38
37 1 5 14 55 59 46
5 88 110
97 1 4 90 108 3 .4 .9 4 .8 36 31 3 39 6 49 16 8
0
5
45 40
6 74 90 86 138 1 0 118 .4 .9 58 -
41 3 - 34 5 10 0 38 36 3
7
68 100 87 118 95 9 .7 .6 . 44 37 4 40 6 5
1
15 -
69 60 6
8 95 1 5 110 140
1 5 130 5 .0 4 .1 3 .7 8 30 35 53 33 34 15 1 65 68 60
9 77 105 98 115 108 98 .7 . 3 .3
43
49
30 35 1 34 6 4 56 56 48
10 63 115
81 116 100 105 .4 .9 3 .0 48 34 35 38 5 37 16 10 8 51 64
53
Mean 8 113 99 1 3 105 108 3 .1 .9
3 .3 41 37 34 40 5 35 13 8 1 53 55 48
SD 14 13 15 10 13 1 0 .9 0 .6 0 .8 9 9 9 8 4 8 7
4 6 10 1 10
<0
.01 <0 .005 <0 .001 NS NS NS NS NS <0 .001 <0 .0 0 .005 0 .06 NS <0 .005
p values <0 .001 <0 .001 NS NS
NS NS <0.005
518
	
BRUSH ET AL .
DRUG EFFECTS ON CARDIAC FUNCTION IN HYPERTENSION
Table . Effects of Nitroprusside and Verapamil at Comparable Heart Rate in 10 Patients
analysis of variance of repeated measures . A p value
<0.05 was considered to be statistically significant .
of
Results
Effects on blood pressure and heart rate . Hemodynamic
data at baseline and during verapamil and nitroprusside
infusions at spontaneous heart rates are shown in Table 1 .
The average mean arterial pressure was 1 3 ± 9 mm Hg
(range 110 to 140). Left ventricular end-diastolic pressure at
baseline was elevated in 5 of the 10 patients . Reflecting the
study design, each drug reduced systemic blood pressure by
approximately 0%. This reduction was associated with
reflex tachycardia, which was more marked during nitro-
prusside infusion .
Hemodynamic data during control conditions and during
nitroprusside and verapamil infusions (with atrial pacing to
attain comparable heart rates) are shown in Table . Heart
rates during control conditions and during nitroprusside and
verapamil infusions were similar (113 ± 18, 118 ± 1 and 113
± 16 beats/min, respectively). Mean arterial pressures were
similar during nitroprusside and verapamil infusions (105
13 versus 109 ± 1 mm Hg) .
Hemodynamic indexes (Table ). Nitroprusside and vera-
pamil had distinctly different effects on cardiac index and
stroke volume index (Fig . 1) . Nitroprusside significantly
decreased cardiac index from 3 . ± 0.7 to .8 ± 0.6
liters/min per m . In contrast, verapamil resulted in no
significant change in cardiac index from control conditions
(3 .3 ± 0.7 versus 3 . ± 0.7 liters / min per m ) . The cardiac
index, however, was significantly higher with verapamil than
with nitroprusside. Similarly, stroke volume index was 8 ±
6 mUm during control conditions, decreased with nitroprus-
T = time constant of isovolumic relaxation ; T-1/ = half time of isovolumic relaxation ; other abbreviations as in Table 1 .
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August 1989:515-
side to 4 ± 5 ml/m and was maintained with verapamil at 30
8
MI/M .
Stroke volume index with verapamil was not
significantly different from that in control conditions, but
was significantly higher than the stroke volume index during
nitroprusside infusion . Systemic vascular resistance index
was 4 ± 8 mm Hg-min m /liter during control conditions
and was not significantly changed with nitroprusside (40 ±
10) . In contrast, systemic vascular resistance index signifi-
cantly decreased to 34 ± 7 mm Hg-min- m /liter with vera-
parnil .
Left ventricular systolic function (Table ). Nitroprusside
and verapamil also had distinctly different effects on ejection
fraction (Fig . ) . Ejection fraction increased significantly
with nitroprusside from 5 ± 9% to 60 ± 14% even though
systemic vascular resistance was unchanged and stroke
volume index was decreased with nitroprusside . With vera-
pamil, ejection fraction decreased in 7 of 10 patients ; how-
ever, important decreases (>_5%) occurred in only 3 patients,
and the mean ejection fraction with verapamil (46 ± 9%) was
not significantly different from that during control condi-
tions. End-systolic volume increased in 8 of 10 patients with
verapamil (Fig . ), and the end-systolic pressure-volume
relation was displaced downward and rightward with vera-
pamil in these 8 patients (Fig . 3), indicating a negative
inotropic effect ( 3) . No such effect was apparent with
nitroprusside ; nitroprusside infusion decreased the end-
systolic volume in all patients (Fig . ), resulting in a down-
ward and leftward shift in the end-systolic pressure-volume
relation in all 10 patients that was compatible with altered
left ventricular loading conditions .
Left ventricular diastolic indexes (Table ). Nitroprusside
and verapamil had opposite effects on left ventricular end-
diastolic volume and pressure (Fig . 4) . During control con-
Patient
No .
Heart Rate
(beats/min)
Mean Arterial
Pressure (mm Hg)
Cardac Index
(liters/min per m )
SVRI
(mm Hg-min•m /liter)
Stroke Volume
Index
(ml/m )
C N V C N V C N
V
C
N V
C N V
1 100 1 5 105 110 90 100 .9 3 .3 3 .9 38
7 6 9 6 37
100 108 101 135
1 0 1 0 .4 .4 .4 56 50 50 4 4
3 130 130 130 115 98 95 .6 1 .9 3 .1
44 5
31
0 15 4
4 130 1 4 1 0 1 0 104
100
3 .4
.7 3 .0 36 39 33 6 5
5
100 110 97 1 8 90 108 3 .8 .9 4 .8 34 31 3 38 6 50
6 79 90 86 139 1 0 118 .5 .3 .9 56
5 41 3 6 34
7 130 130 130
140 9 96 3 .5 .8 3 . 40 33 30 7 1 5
8 130 1 5 130 135 1 5 130 4 .7 4 .1 3 .6 9 30 36 36
33
8
9 130 119 130 1 4 108 108 .8 . 3 .1
44 49 35 19 4
10 100
115 100 1 8 100 118 3 .0 .9 3 . 43 34 37 30 5 3
Mean 113 118 113 1 7 105 109 3 . .8 3 .3 4 40 34 8 4 30
SD 18
1 16 10 13 1 0 .7 0 .6 0 .7 8 10 7 6 5 8
NS NS <0 .05 NS <0.05 <0.005 NS <0 .05 <0 .01 <0 .0005
p values NS <0.05 NS <0.005 NS
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Table . Continued
ditions, left ventricular end-diastolic volume index was 57
16 ml/m , significantly decreasing with nitroprusside to 41 ±
10 MUM
.
In contrast, left ventricular end-diastolic volume
index increased significantly with verapamil to 70 ± 8
MI/M
. The change in end-diastolic volume index with vera-
pamil correlated positively with the change in stroke volume
index (r = 0 .8 , p < 0 .005) (Fig . 5) . The change in end-
diastolic volume did not correlate with the change in end-
diastolic pressure during either verapamil or nitroprusside
infusion .
Although left ventricular end-diastolic pressure was not
altered significantly from control by either nitroprusside or
verapamil (Table ), the end-diastolic pressure was signifi-
cantly less during nitroprusside compared with verapamil
(p < 0.005) (Fig. 4). The end-diastolic pressure-volume
relation shifted downward and leftward in 7 of the 10 patients
during nitroprusside infusion . In contrast, during verapamil
infusion, it shifted downward and rightward in two patients,
Figure 1 . Cardiac index and stroke volume index during control
conditions and during nitroprusside and verapamil infusion .
5 .0
4 .0
3 .0x
U
.0
0
1 .0
10,
p <0.05
p=NS
p <0.005
Control Nitres Verapamil
pnrseide
50
Control Nitro- VerapamN
prusside
rightward with no vertical change in two and upward and
rightward in six .
The time constant of isovolumic relaxation was not
significantly different during control conditions (8 ± 34 ms),
with nitroprusside (75 ± 16 ms) or with verapamil (9 ± 33
ms). The half-time of isovolumic pressure decline (T-1/ )
was 38 ± 5 ms during control conditions and was not
significantly changed during either nitroprusside (36 ± 3 ms)
or verapamil (41 ± 4 ms) infusion. The T-1/ was signifi-
cantly less during nitroprusside compared with verapamil
(p < 0.05) .
Coronary blood flow was 96 ml/min and coronary resis-
tance was 1 .6 mm Hg-min/ml during control conditions .
Coronary blood flow and coronary resistance were not
Figure . Left ventricular ejection fraction and left ventricular
end-systolic volume index during control conditions and during
nitroprusside and verapamil infusion .
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LV End-Diastolic
Volume Index
(mUm )
LV End-Diastolic
Pressure (mm Hg)
LV End-Systolic
Volume Index (mUm )
LV Ejection
Fraction (%) T (ms) T-1/ (ms)
C N V C N V C N V C N V C N V C N V
63 48 84 5 9 11 34 47 46 55 44 66 84 61 38 41 39
39 3 40 6 4 1 15 10 16 6 70
60
4
80
67
9 39
37
51 37 65 8 6 5 31 3 4l 39 39 37 56 55 6 33 31 33
44 37 64 1 5 14
18 15
39
59 59 39 76 8
79
40 37 41
75 48 141 10 3 0 37 9 51 55 35 - - - - - -
89
6
91 14 6 36 37 57 36 41 37 104 8 98 43 39 43
43 5 55 1 15 1 16 4 30 63 85 46 70 79 80 39 35 39
64
48
47
1
14 1 8 15 19 56 68 59 60 91 163 39 35 51
39 30 44 6 4 17
1
0
56
61
54
110
41 101 39 35 39
64 39 64 16 10 0 34 14 3 47 64 50 15 77 118 43 35 43
57
41
70 10 7 13 9 17 39 5 60 46 8 75 9 38 36 41
16 10 8 4 4 6 1 9 1 9 14 9 34 16 33 5 3 4
<0.05 <0 .0005 NS <0.005 <0 .05 <0.0005 <0 .05 <0 .0005 NS NS NS <0.05
<0 .05 NS
<0
.05 NS
NS NS
//
0
10
p<0 .01
P=NS
P <0.0005
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Figure 3 . Left ventricular (LV) pressure-volume relations during
control conditions (solid circles) and during nitroprusside (open
circles) and verapamil (triangles) infusion .
significantly altered by either nitroprusside (85 ml/min and
1 .4 mm Hg-min/ml) or verapamil (94 ml/min, 1 .5 mm
Hg-min/ml) .
Discussion
In this study of 10 symptomatic patients with systemic
hypertension, nitroprusside and verapamil were adminis-
tered sequentially, and patients were paced atrially before
and during drug infusions to allow a direct comparison of the
drug effects on cardiac function at matched mean aterial
pressures and heart rates . The findings of this study indicate
that, under these acute study conditions, the two drugs have
markedly different effects on cardiac index, systemic vascu-
lar resistance and left ventricular volume indices .
Figure 4 . Left ventricular end-diastolic volume index and pressure
during control conditions and during nitroprusside and verapamil
infusion .
14
100
75
140 -
150
50
Control Nitro- Verapamil
prusside
w
LU
5
Cc
U
0 0
dE
w E
15
p <0.005
p=ISIS
p = NS
Control
Nitro- Verapamil
prusside
CHANGE IN EDVI FROM CONTROL
(ml/m )
Figure 5 . Change in stroke volume index (SVI) with verapamil
plotted as a function of the change in end-diastolic volume index
(EDVI) with verapamil .
Cardiac effects of verapamil . Verapamil infusion resulted
in a negative inotropic effect as evidenced by a downward
and rightward shift in the pressure-volume relation in 8 of the
10 patients ( 3) . Despite the negative inotropic effect, car-
diac index and stroke volume index were maintained during
verapamil infusion . These findings indicate that the negative
inotropic action of verapamil was balanced by two additional
drug effects . First, verapamil reduced systemic arterial re-
sistance, and diminished arterial impedance served to aug-
ment stroke volume despite reduced contractile state . Sec-
ond, our data suggest that left ventricular filling was
enhanced by verapamil . The significant increase in end-
diastolic volume in the absence of a significant increase in
end-diastolic pressure and the significant correlation be-
tween increased end-diastolic volume and augmented stroke
volume (Fig . 5) both argue strongly that the increase in
end-diastolic volume did not result merely from negative
inotropic mechanisms .
From our data it is not possible to draw firm conclusions
concerning the mechanism responsible for the increase in
left ventricular end-diastolic volume induced by verapamil .
It is possible that verapamil directly enhanced left ventricu-
lar relaxation by reducing calcium influx through its calcium
channel-blocking properties . However, the time constant of
isovolumic relaxation and the half-time of isovolumic pres-
sure decline were not decreased significantly during vera-
pamil infusion. Therefore, the beneficial effect of verapamil
on left ventricular diastolic filling is not reflected by these
indexes of left ventricular relaxation . The apparent improve-
ment in left ventricular filling during verapamil infusion is
also not related to changes in coronary blood flow, which
was not affected by verapamil, nor is it likely that verapamil
affected sympathetic activation more than nitroprusside to
secondarily affect left ventricular filling . Nevertheless, it
appears that verapamil had an overall favorable effect on the
JACC Vol . 14, No .
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complex interplay of factors that affect ventricular filling
( 4- 6), resulting in increased left ventricular volume . In this
regard, the effect of verapamil on ventricular filling and
diastolic pressure-volume relations in hypertensive patients
is similar to the effect of calcium channel blocking agents
previously demonstrated in patients with hypertrophic car-
diomyopathy (8-10,1 ) and coronary artery disease (14,16) .
Cardiac effects of nitroprusside . Under rest conditions,
nitroprusside caused significant reflex tachycardia that main-
tained cardiac output . When compared with verapamil at
matched heart rates, however, it was apparent that the two
drugs had markedly different effects . Nitroprusside caused a
significant decrease in cardiac index and stroke volume
index related to a significant decrease in left ventricular
end-diastolic volume index (Fig
. 5) . Nitroprusside did not
alter systemic arterial resistance . Thus, the principal effect
of nitroprusside was a reduction in left ventricular preload .
The decrease in cardiac index with nitroprusside indicates a
dependence of the hypertensive ventricle on adequate left
ventricular preload to maintain cardiac output. Ejection
fraction increased with nitroprusside but, considering the
effects on systemic vascular resistance and stroke volume,
this appeared to reflect merely the short-term alteration in
relative end-diastolic and end-systolic volumes arising from
reduced preload rather than from a peripheral unloading
effect .
The half-time of pressure decay during isovolumic relax-
ation (T-1/ ) was significantly less, and the time constant of
exponential isovolumic pressure decline tended to be less
during nitroprusside infusion as compared with verapamil
infusion. Because isovolumic relaxation can be affected by
the extent of end-systolic fiber shortening ( , 7, 8) and
because end-systolic volume index was significantly reduced
during nitroprusside infusion, it is likely that the degree
of
end-systolic fiber shortening accounted for the significant
decline in both T-1/ and the time constant (T) .
Moreover,
the lack of reduction in these time constants during vera-
pamil could reflect the reduced end-systolic fiber shortening
and increased end-systolic volumes stemming from the neg-
ative inotropic effects .
The reduction in cardiac index associated with a decrease
in left ventricular end-diastolic volume with nitroprusside
was opposite to the effect of nitroprusside reported previ-
ously in patients with left ventricular systolic dysfunction
and chronic volume overload ( 8), but similar to the effect
previously reported in hypertensive patients ( 9) . In the
present study, there was no decrease in systemic vascular
resistance during nitroprusside infusion, and the decrease in
mean arterial pressure resulted mainly from reduced cardiac
index. In contrast, verapamil caused a 19% reduction in
systemic vascular resistance
. Thus, the mechanisms for the
reduction in blood pressure by the two drugs were clearly
different . Nitroprusside reduced blood pressure principally
by diminishing cardiac index stemming from decreased
preload . Because cardiac index was maintained with vera-
pamil, blood pressure reduction with verapamil was accom-
plished to a similar degree through a predominant effect on
arterial resistance .
Clinical implications . These data have practical implica-
tions concerning treatment of hypertensive patients. Be-
cause diastolic dysfunction is not uncommon in patients with
hypertension and left ventricular hypertrophy (5,6), an opti-
mal antihypertensive agent would lower systemic blood
pressure while favorably affecting left ventricular diastolic
filling . Our data indicate that verapamil has such properties
after acute administration in symptomatic patients, although
the negative inotropic effect might limit its use in patients
with impaired left ventricular systolic function .
Our data concerning the short-term hemodynamic effects
of nitroprusside in hypertension also have possible implica-
tions regarding the effects of other vasodilating agents with
venodilating effects that are used for long-term treatment
of hypertension. Although compensatory hemodynamic
changes are likely to occur with long-term therapy, it is also
likely that antihypertensive agents that have purely vasodi-
lating actions may have deleterious effects on left ventricular
filling in hypertensive patients . In patients with severe left
ventricular hypertrophy, antihypertensive therapy with such
vasodilating agents has been associated with severe adverse
consequences (30) . Our data provide a hemodynamic mech-
anism that could explain the previously reported clinical
findings and suggest that deleterious hemodynamic effects
can occur in hypertensive patients with impaired left ven-
tricular filling even in the absence of severe left ventricular
hypertrophy .
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